Prevalence of obesity in people with and without type 1 diabetes across Belgium, Kuwait, and Mexico: an IMI2 SOPHIA study

This manuscript is part of the Stratification of Obesity Phenotypes to Optimize Future Obesity Therapy (SOPHIA) project (www.imisophia.eu). SOPHIA has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No. 875534. This Joint Undertaking support from the European Union's Horizon 2020 research and innovation program and EFPIA and type 1 diabetes Exchange, Breakthrough T1D, and Obesity Action Coalition.

Authors

Institutions

Publication Details

Journal
EClinicalMedicine
Published
2024-10-03
DOI
https://doi.org/10.1016/j.eclinm.2024.102869
Citations
10
Primary Topic
Diabetes Management and Research
Type
article
Field-Weighted Citation Impact
3.58

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prevalence of obesity in people with and without type 1 diabetes across Belgium, Kuwait, and Mexico: an IMI2 SOPHIA study

Jumana Al Kandari, Carel Wynand le Roux, Mohammad Irshad, Nele Steenackers et al.
10 citations
EClinicalMedicine
Diabetes Management and Research
3.58
article

Prevalence of obesity in people with and without type 1 diabetes across Belgium, Kuwait, and Mexico: an IMI2 SOPHIA study

Jumana Al Kandari, Carel Wynand le Roux, Mohammad Irshad, Nele Steenackers, Ebaa Al‐Ozairi, J. Craig Longenecker, Jonathan Rosen, Sofia Pazmiño, Raquel N. Faradji, Chantal Mathieu, Carl Delfin, Thomas Sparsø, Carmen Hurtado del Pozo, Astrid Lavens, Paloma Almeda‐Valdés, Neftalí Eduardo Antonio-Villa, Bart Van der Schueren, Aili García-Tuomola A, Abdulnabi Alattar
article en
10 citations

Abstract

This manuscript is part of the Stratification of Obesity Phenotypes to Optimize Future Obesity Therapy (SOPHIA) project (www.imisophia.eu). SOPHIA has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No. 875534. This Joint Undertaking support from the European Union's Horizon 2020 research and innovation program and EFPIA and type 1 diabetes Exchange, Breakthrough T1D, and Obesity Action Coalition.

EClinicalMedicineVol. 77
University College Dublin (IE), Novo Nordisk (Denmark) (DK), Amiri Hospital (KW), Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (MX), Breakthrough (US), Ministry of Health (KW), Centro Médico ABC (MX), Sciensano (Belgium) (BE), Instituto Nacional de Cardiología (MX), Dasman Diabetes Institute (KW), Drexel University (US), KU Leuven (BE)
European Federation of Pharmaceutical Industries and Associations, European Commission
Zero hunger
Openalex Percentile: Top 6%
Diabetes Management and Research
3.58
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.